Navigation Links
Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
Date:3/4/2013

requent adverse events (AEs) in STARTVerso™ 4 were nausea (37%), fatigue (33%), diarrhea (27%), headache (23%), and weakness (22%). Serious AEs were reported in 32 patients (10%), including three deaths. To date, 18 patients have discontinued study participation due to AEs. The safety results of this study were comparable to those observed in HCV mono-infected treatment-naive patients in prior faldaprevir clinical studies. No patient on ART experienced a loss of HIV viral suppression during the study period.

In a separate oral presentation at CROI, investigators described the results from three open-label Phase 1 studies in healthy volunteers that evaluated the drug-drug interactions of faldaprevir with the common HIV medications darunavir/ritonavir, efavirenz, or tenofovir. In each of these studies, there was no clinically relevant effect of faldaprevir on the pharmacokinetics of any of the HIV medications studied. However, the respective effects of darunavir/ritonavir and efavirenz on faldaprevir informed the study design of STARTVerso™ 4. Patients already taking darunavir/ritonavir or efavirenz were enrolled into the 120mg and 240mg faldaprevir groups in STARTVerso™ 4, respectively.

These drug-drug interaction findings are part of a comprehensive program to evaluate potential drug interactions of faldaprevir with other medications commonly taken by the diverse patient populations infected with HCV. Most AEs in the drug-drug interaction studies were mild or moderate and all were resolved by the end of the trials. Four healthy volunteers discontinued trial participation due to AEs, including mild or moderate rash, mild elevation in hepatic enzyme levels, or moderate myalgia.

"The interim virologic response rates from STARTVerso™ 4 in HCV/HIV co-infected patients, combined with the drug-drug interaction results of faldaprevir with common HIV medications, are encouraging as we continue toward our goal of developing new HCV
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , Mar. 05, 2015 Research and ... the addition of the "Global Pharma US ... Cost Optimization Plays Major Role In Shaping Up ... to their offering. Strategy Diversification ... in healthy Cash position- Will accelerate Next wave ...
(Date:3/5/2015)... , March 5, 2015 Soligenix, Inc. (OTCQB: ... company committed to developing products that address unmet medical ... announced today that its President and Chief Executive Officer, ... corporate presentation at the 27 th Annual ROTH ... on Tuesday, March 10, 2015 at 1:00 PM Pacific ...
(Date:3/5/2015)...  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... to be held March 8-11, 2015, in ... Sapirstein , Chief Executive Officer, will provide an overview ... will be available to participate in one-on-one meetings with ...
Breaking Medicine Technology:Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 2Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 3Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3ContraVir to Present at 27th Annual ROTH Conference 2
... Marshall Edwards, Inc.(Nasdaq: MSHL ), an ... anti-cancer therapeutics, announced today that it was notified on ... The NASDAQ Stock Market that, due to the Company,s ... for continued listing on The NASDAQ Global Market, as ...
... Nov. 18, 2010 Ethicon, Inc., a worldwide leader ... submitted a Biologic License Application (BLA) to the U.S. ... a novel product candidate that combines Ethicon,s biomaterials and ... in stopping soft tissue bleeding during surgery. ...
Cached Medicine Technology:Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing 2Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing 3Ethicon Submits Biologic License Application to the FDA for the Fibrin Pad 2Ethicon Submits Biologic License Application to the FDA for the Fibrin Pad 3
(Date:3/5/2015)... (PRWEB) March 05, 2015 Leading nutritional ... this week’s Arnold Sports Festival and Arnold Fitness ... Metabolic Nutrition will host a display booth featuring ... pre-workout E.S.P. and its highly-popular, class-leading fat burner Synedrex. ... cups, unique recipes that utilize its top-of-the-line supplements and ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 The ... week released a special issue devoted ... field of PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated ... an autoimmune reaction triggered by infections such as ... result in inflammation of the child's brain. This ...
(Date:3/5/2015)... Kevin Batsford lost his brother in ... drug addiction. The siblings frequented bridges, highways, and obscure ... seek refuge during the night. Batsford said that is ... his outward appearance, hygiene, or overall well being- outside ... reported on Feb. 23rd that Batsford left behind ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Altec Products, ... solutions, announced today their participation in the Houston, TX ... 2015. The Inspire Tour will unite Sage enterprise resource ... ideas about workable solutions to real-world business challenges. ... the Crowne Plaza Houston Galleria Area on March 10th. ...
(Date:3/5/2015)... Colorful packaging and marketing promises make it ... health. But all it really takes is reading the ... the March 2015 Harvard Health Letter . , ... director of the Department of Nutrition at Harvard-affiliated Brigham ... all the markers of good nutrition. , Whole grains ...
Breaking Medicine News(10 mins):Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 2Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 3Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 2Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 3Health News:Tips to Find the Healthiest Breakfast Cereals, From the March 2015 Harvard Health Letter 2
... such an essential part of human existence that we spend ... more successfully than others. Sleep disorders afflict some 50-70 million ... of disease and injury. People who suffer from disturbed sleep ... depression, and accidents. Nearly a fifth of all serious car ...
... Updated Interoperability RequirementsTAMPA, Fla., April 15 Sage ... health records, today announced that The Certification Commission ... product, Sage Intergy EHR, as a ... , additionally certified for Child Health and Cardiovascular ...
... MEMPHIS, Tenn., April 15 The Harvard Business ... the growth and impact of Youth Villages, a private ... through its Intercept program and has become a national ... the last decade. Written by HBS Professor Allen Grossman, ...
... AIDS for years after initial infection by HIV have ... One component of this remarkable resistance comes from an ... genes that help the immune system recognize and fight ... the Emory Vaccine Center studying HIV-infected people with particularly ...
... approach to treat stomach cancer has been shown to ... for some patients. , A new study led by ... "open" surgery to remove the stomach with laparoscopic gastrectomy ... removes the stomach while guided by a magnified image ...
... Carl Icahn announced today that he had sent the following letter to Joseph C. Cook, Jr., Chairman ... to take place at the forthcoming annual meeting of Amylin,s stockholders:, ... ... April 15, 2009, Mr. Joseph C. Cook, Jr., Chairman of ...
Cached Medicine News:Health News:New way to analyze sleep disorders 2Health News:New way to analyze sleep disorders 3Health News:Sage Intergy EHR Receives 08 CCHIT Certification 2Health News:Sage Intergy EHR Receives 08 CCHIT Certification 3Health News:Sage Intergy EHR Receives 08 CCHIT Certification 4Health News:Sage Intergy EHR Receives 08 CCHIT Certification 5Health News:Harvard Business School Publishes Case Study on Youth Villages-Intercept in Texas 2Health News:Harvard Business School Publishes Case Study on Youth Villages-Intercept in Texas 3Health News:Harvard Business School Publishes Case Study on Youth Villages-Intercept in Texas 4Health News:HIV handicaps itself to escape immune system pressure 2Health News:New minimally invasive surgery option for patients with stomach cancer 2Health News:Letter From Carl Icahn to Amylin Pharmaceutical, Inc. 2Health News:Letter From Carl Icahn to Amylin Pharmaceutical, Inc. 3Health News:Letter From Carl Icahn to Amylin Pharmaceutical, Inc. 4Health News:Letter From Carl Icahn to Amylin Pharmaceutical, Inc. 5
Detect LH surge for predicting ovulation, Able to detect as low as 40 mIU/mL LH or 30 mIU/mL LH, Simple, easy and accurate, Built-in control system...
... Fertility Monitor has been designed for women actively ... algorithm to help identify the time of high ... before a woman reaches her peak fertility. By ... The product comprises a number of test sticks ...
... enables the fast and exact determination of ... handy photometer and micro-cuvettes, filled with dry ... or arterial blood should be taken with ... so filled cuvette can now be inserted ...
STAT-CRIT is a rapid, one-step system for measuring hematocrit....
Medicine Products: